Detecting Potential Formulation Roadblocks in Early Drug Development

Apr 13, 2018
By Pharmaceutical Technology Editors

Pharmaceutical Technology will host a panel discussion,Detecting Potential Formulation Roadblocks in Early Drug Development, on April 24, 2018 at CPhI North America in Philadelphia, PA.

In the discussion, moderated by Rita Peters, editorial director of Pharmaceutical TechnologyPharmaceutical Technology Europe, and BioPharm International, a panel of experts will explore tools, strategies, and methods for assessing the formulation, drug delivery, and manufacturing potential of a drug candidate in preclinical phases.  Implications for timelines, API materials, and budgets will also be discussed.

Panelist include Stephen Tindal, director of Science Affairs at Catalent Pharma Solutions, and Ronald D. Snee, PhD, founder and president at Snee Associates, a consultancy that provides guidance for improved business performance using data-based improvement approaches such as lean six sigma and quality by design.

For more information and to register for the event, visit www.cphinorthamerica.com.

Source: CPhI North America

native1_300x100
lorem ipsum